What’s New

Tennessee Poll Shows Impact of Non-Medical Switching

Polling results from Tennessee cast new light on a trend that’s sparking national concerns: non-medical switching. As the Tennessee Patient Stability Coalition reports, more than

Read More

“Accessing Cholesterol Treatments” is No Simple Task, Explains New Video

On the heels of recent research confirming breakthrough drugs’ impact on patients with high cholesterol, the Partnership to Advance Cardiovascular Health has released a quick-draw

Read More

The Wait Continues for Medicaid Patients with Hepatitis C

Despite being cautioned last year by the Centers for Medicare and Medicaid Services, many states still block patients with hepatitis C from receiving curative treatment.

Read More

Will New Evidence on PCSK9 Inhibitors Improve Patient Access?

For patients with extremely high cholesterol, the promise of new PCSK9 inhibitors just keeps growing. Data presented at this month’s American Heart Association meeting confirms

Read More

COPD Awareness Month Spotlights Screening, Access Woes

Chronic obstructive pulmonary disease, or COPD, often exists undiagnosed and goes undertreated. Perhaps that’s why it continues to be the third leading cause of death

Read More

Physicians Align on Meaningful Biosimilar Suffixes

The Food and Drug Administration may not have reached consensus on the suffixes that distinguish biological and biosimilar medications, but physicians are of one mind:

Read More

IfPA White Paper Identifies Barriers to Cardiovascular Treatments

Cardiovascular disease cuts across ethnicities and demographics as the leading cause of death in the United States, explains a new white paper from the Institute

Read More

RSV Season Takes Toll on Preterm Infants and Senior Citizens

One month into the Respiratory Syncytial Virus season, data shows that the disease is taking its toll.   RSV is a contagious seasonal virus that causes

Read More

Prisons Keep Hepatitis C Cures Under Lock and Key

State prisoners have a higher-than-average rate of hepatitis C infection, but their chances of accessing a cure are uncommonly slim. A new study from Health

Read More

Orphan Drug Access Still Eludes Some Cystic Fibrosis Patients

More than a year after a breakthrough drug for cystic fibrosis became available, fewer than half of patients who meet the Food and Drug Administration’s

Read More
Back to Top